Search Results - "Sherr, Jennifer"

Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults by Sherr, Jennifer L

“…As hybrid closed-loop (HCL) insulin delivery systems permeate clinical practice, it is critical to ensure all with diabetes are afforded the opportunity to…”
Get full text

Type 1 diabetes glycemic management: Insulin therapy, glucose monitoring, and automation by Perkins, Bruce A, Sherr, Jennifer L, Mathieu, Chantal

“…Despite innovations in insulin therapy since its discovery, most patients living with type 1 diabetes do not achieve sufficient glycemic control to prevent…”
Get full text

Making diabetes technology accessible to all by Nally, Laura M., Sherr, Jennifer L.

“…As diabetes technology evolves, implementation of equitable, sustainable, remote patient monitoring will ensure that this technology is accessible to everyone…”
Get full text

Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial by Forlenza, Gregory P, McVean, Jennifer, Beck, Roy W, Bauza, Colleen, Bailey, Ryan, Buckingham, Bruce, DiMeglio, Linda A, Sherr, Jennifer L, Clements, Mark, Neyman, Anna, Evans-Molina, Carmella, Sims, Emily K, Messer, Laurel H, Ekhlaspour, Laya, McDonough, Ryan, Van Name, Michelle, Rojas, Diana, Beasley, Shannon, DuBose, Stephanie, Kollman, Craig, Moran, Antoinette

“…IMPORTANCE: In preclinical studies, thioredoxin-interacting protein overexpression induces pancreatic beta cell apoptosis and is involved in…”
Get full text

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies by Sherr, Jennifer L., Tauschmann, Martin, Battelino, Tadej, de Bock, Martin, Forlenza, Gregory, Roman, Rossana, Hood, Korey K., Maahs, David M.

Get full text

Answering clinically pertinent questions with real-world data from paediatric type 1 diabetes registries by Galderisi, Alfonso, Sherr, Jennifer L

Get full text

Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes by Hirsch, Irl B, Sherr, Jennifer L, Hood, Korey K

Get full text

Response to: MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias-Response to Inaccurate Allegations by Forlenza, Gregory P, Sherr, Jennifer L

Get more information

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System by Messer, Laurel H, Forlenza, Gregory P, Sherr, Jennifer L, Wadwa, R Paul, Buckingham, Bruce A, Weinzimer, Stuart A, Maahs, David M, Slover, Robert H

“…The MiniMed 670G System is the first commercial hybrid closed-loop (HCL) system for management of type 1 diabetes. Using data from adolescent and young adult…”
Get full text

Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries by Sherr, Jennifer L., Hermann, Julia M., Campbell, Fiona, Foster, Nicole C., Hofer, Sabine E., Allgrove, Jeremy, Maahs, David M., Kapellen, Thomas M., Holman, Naomi, Tamborlane, William V., Holl, Reinhard W., Beck, Roy W., Warner, Justin T.

“…Aims/hypothesis While the use of insulin pumps in paediatrics has expanded dramatically, there is still considerable variability among countries in the use of…”
Get full text

Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative by DeSalvo, Daniel J., Miller, Kellee M., Hermann, Julia M., Maahs, David M., Hofer, Sabine E., Clements, Mark A., Lilienthal, Eggert, Sherr, Jennifer L., Tauschmann, Martin, Holl, Reinhard W.

“…Background To assess the change in rates of pediatric real‐time or intermittent scanning continuous glucose monitoring (CGM) use over the past 5 years, and how…”
Get full text

Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study by Shah, Viral N, DuBose, Stephanie N, Li, Zoey, Beck, Roy W, Peters, Anne L, Weinstock, Ruth S, Kruger, Davida, Tansey, Michael, Sparling, David, Woerner, Stephanie, Vendrame, Francesco, Bergenstal, Richard, Tamborlane, William V, Watson, Sara E, Sherr, Jennifer

“…Abstract Context Use of continuous glucose monitoring (CGM) is increasing for insulin-requiring patients with diabetes. Although data on glycemic profiles of…”
Get full text

High residual C-peptide likely contributes to glycemic control in type 1 diabetes by Rickels, Michael R, Evans-Molina, Carmella, Bahnson, Henry T, Ylescupidez, Alyssa, Nadeau, Kristen J, Hao, Wei, Clements, Mark A, Sherr, Jennifer L, Pratley, Richard E, Hannon, Tamara S, Shah, Viral N, Miller, Kellee M, Greenbaum, Carla J

“…BACKGROUNDResidual C-peptide is detected in many people for years following the diagnosis of type 1 diabetes; however, the physiologic significance of low…”
Get full text

Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association by Sherr, Jennifer L, Heinemann, Lutz, Fleming, G Alexander, Bergenstal, Richard M, Bruttomesso, Daniela, Hanaire, Hélène, Holl, Reinhard W, Petrie, John R, Peters, Anne L, Evans, Mark

“…A technological solution for the management of diabetes in people who require intensive insulin therapy has been sought for decades. The last 10 years have…”
Get full text

Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey by Sherr, Jennifer L, Laffel, Lori M, Liu, Jingwen, Wolf, Wendy, Bispham, Jeoffrey, Chapman, Katherine S, Finan, Daniel, Titievsky, Lina, Liu, Tina, Hagan, Kaitlin, Gaglia, Jason, Chandarana, Keval, Bergenstal, Richard, Pettus, Jeremy

“…To determine how diabetes technologies, including continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems, impact glycemic metrics,…”
Get full text

Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association by Sherr, Jennifer L., Heinemann, Lutz, Fleming, G. Alexander, Bergenstal, Richard M., Bruttomesso, Daniela, Hanaire, Hélène, Holl, Reinhard W., Petrie, John R., Peters, Anne L., Evans, Mark

“…A technological solution for the management of diabetes in people who require intensive insulin therapy has been sought for decades. The last 10 years have…”
Get full text

Enlarging the loop: closed-loop insulin delivery for type 1 diabetes by Galderisi, Alfonso, Sherr, Jennifer L

“…A growing number of clinical trials have shown that home use of hybrid closed-loop insulin delivery systems reduces time spent in hypoglycaemia and improves…”
Get full text

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery by Sherr, Jennifer L., Schoelwer, Melissa, Dos Santos, Tiago Jeronimo, Reddy, Leenatha, Biester, Torben, Galderisi, Alfonso, Dyk, Jacobus Cornelius, Hilliard, Marisa E., Berget, Cari, DiMeglio, Linda A.

Get full text

The Acute Effects of Real-World Physical Activity on Glycemia in Adolescents With Type 1 Diabetes: The Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) Study by Riddell, Michael C, Gal, Robin L, Bergford, Simon, Patton, Susana R, Clements, Mark A, Calhoun, Peter, Beaulieu, Lindsey C, Sherr, Jennifer L

“…Data from the Type 1 Diabetes Exercise Initiative Pediatric (T1DEXIP) study were evaluated to understand glucose changes during activity and identify factors…”
Get full text

A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective by Jendle, Johan, Adolfsson, Peter, Choudhary, Pratik, Dovc, Klemen, Fleming, Alexander, Klonoff, David C., Mader, Julia K., Oliver, Nick, Sherr, Jennifer L., Šoupal, Jan, Heinemann, Lutz

“…People living with diabetes have many medical devices available to assist with disease management. A critical aspect that must be considered is how systems for…”
Get full text